There’s huge news coming out of Washington, D.C., and it could mark a meaningful turning point for the cannabis industry nationwide.
On December 18, President Trump signed an executive order directing the federal government to expedite the rescheduling of marijuana from a Schedule I substance to a less restrictive Schedule III under the Controlled Substances Act. While the process is not finalized yet, the move signals real momentum toward long-awaited federal reform, building on a review that began under the Biden administration but stalled before completion.
For cannabis businesses, researchers, medical professionals, and patients, this announcement represents progress. And here on Aquidneck Island, it’s a moment worth paying attention to. Keep reading to learn more!
What Does Cannabis Rescheduling Actually Mean?
Under federal law, Schedule I drugs are defined as having no accepted medical use and a high potential for abuse. Cannabis has been classified this way for decades (alongside substances like heroin) despite overwhelming evidence of its medical applications and widespread legalization at the state level.
Moving cannabis to Schedule III would officially acknowledge its medical value and place it alongside medications like ketamine and certain anabolic steroids. While it would not legalize cannabis federally or override state laws, the change could have wide-reaching implications, including:
- Expanded cannabis research, making it easier for scientists and institutions to study the plant
- Greater clarity for doctors and patients, especially in medical cannabis programs
- Improved investment and lending conditions for cannabis businesses
- Potential tax relief for retailers currently impacted by restrictive federal tax rules
For small and independent operators in particular, these shifts could ease long-standing financial pressure and create a more sustainable path forward.
Why This Matters for Rhode Island
Rhode Island’s legal cannabis market has grown steadily, but like every state-regulated market, it still operates under the shadow of federal prohibition. Cannabis businesses comply with strict local regulations while navigating federal policies that were never designed for a modern, legal industry.
Rescheduling could help align state and federal perspectives (especially when it comes to research, medical use, and taxation). While it won’t change everything overnight, it’s a step toward treating cannabis like the legitimate industry it already is in Rhode Island.
Newport Cannabis Co. Recognizes the Moment
Here on Aquidneck Island, Newport Cannabis Co. is marking this moment with intention.
Founded on a belief in the medical and therapeutic properties of cannabis, Newport Cannabis Co. sees the federal announcement as progress toward broader understanding and acceptance of the plant, even as the formal rescheduling process continues.
Founder Octavius Prince shared his thoughts on the announcement:
“We are extremely pleased to hear the news of the federal government taking steps to move this process forward. Newport Cannabis Co. is passionate about educating the public on the benefits of legal cannabis, and we welcome Rhode Islanders to stop by with questions. There’s going to be a lot of information circulating, and we encourage people to come talk to those who live, breathe, and work with Rhode Island cannabis every day.”
To recognize the announcement, Newport Cannabis Co. will be offering special in-store surprises on Friday, December 19, inviting the community to stop by, ask questions, and learn more about what this shift could mean locally.
So, What Happens Next?
It’s important to note that this executive order does not immediately reschedule cannabis. Instead, it directs the Attorney General and federal agencies to speed up the review and decision-making process. That means changes will still take time, and state laws remain fully in effect.
However, momentum matters.
For an industry that has spent decades operating in legal gray areas, federal acknowledgment (especially around medical legitimacy) represents meaningful progress.
Key Takeaways:
1. What is cannabis rescheduling?
Cannabis rescheduling is the process of moving marijuana from a Schedule I classification to a lower schedule under federal law. This change would officially recognize its medical use.
2. Does this mean cannabis is now federally legal?
No. Rescheduling does not legalize cannabis federally or override state laws. State cannabis programs, including Rhode Island’s, remain in place.
3. What does Schedule III mean for cannabis?
Schedule III status would place cannabis alongside medications like ketamine and certain anabolic steroids, acknowledging medical value while keeping regulations in place.
4. Who could benefit from cannabis rescheduling?
Researchers, medical professionals, patients, and cannabis businesses could all benefit through expanded research access, clearer medical guidance, improved financial conditions, and potential tax relief.
A Moment for Education & Conversation
With major headlines comes major confusion. Newport Cannabis Co. medical and recreational dispensary encourages Rhode Islanders to approach this moment with curiosity and informed questions. Whether you’re a medical patient, an adult-use consumer, or simply interested in how policy shapes local businesses, education remains key.
Cannabis reform doesn’t happen all at once, but moments like this show that the conversation is evolving.
Stop by Newport Cannabis Co., connect with knowledgeable staff, and stay tuned as the industry continues to move forward, one step at a time.
The contents of this blog are intended for informational purposes only. Always seek the advice of a physician or other qualified healthcare provider with any questions you may have regarding a medical condition.